Home › Astrocytoma › Wisconsin › Madison
Astrocytoma clinical trials in Madison, WI
3 studies for Astrocytoma are looking for participants at sites in and around Madison (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
RecruitingPhase 3
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
RecruitingPhase 1
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RecruitingPhase 3
- University of Wisconsin Health, Madison
Astrocytoma trials in other cities
- Houston, TX15 studies
- Boston, MA13 studies
- New York City, NY10 studies
- Chicago, IL9 studies
- Seattle, WA7 studies
- Philadelphia, PA7 studies
- Miami, FL7 studies
- Durham, NC7 studies
- San Francisco, CA6 studies
- Columbus, OH6 studies
- Aurora, CO6 studies
- Washington, DC5 studies
Other studies in Madison
- Prostate Cancer29 studies
- Breast Cancer22 studies
- Colorectal Cancer22 studies
- Metastatic Cancer20 studies
- Acute Myeloid Leukemia17 studies
- Melanoma15 studies
- Non-Small Cell Lung Cancer14 studies
- Cancer (all types)14 studies
- Ovarian Cancer14 studies
- Lung Cancer11 studies
- Stomach Cancer11 studies
- Pancreatic Cancer9 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.